Inve India ▾
ININNOVACAP

Innova Captab Q1 FY27 results (Apr–Jun 2026) and concall

Healthcare · Concall AI · Call held 12 Aug 2026

Innova Captab Limited delivered a strong Q1 FY27, with consolidated revenue growing 34% year-on-year to INR470.9 crores and EBITDA increasing 33% to INR75.1 crores. Both CDMO and branded generic segments showed robust growth, with the newly commissioned Jammu facility also turning EBITDA positive. While gross margins experienced a slight dip due to business mix, the company remains confident in its 20% plus volume growth guidance and long-term profitability targets.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

Q1 FY27: revenue up 33.8%, net profit up 41.9% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue318 316 315 352 380 +19%450 +42%448 +42%471 +34%
EBITDA50 47 48 52 52 +4%69 +47%65 +35%73 +40%
Net profit35 34 30 31 30 −14%42 +24%38 +27%44 +42%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.